13,754 Shares in Health Catalyst, Inc. (NASDAQ:HCAT) Purchased by OneAscent Financial Services LLC

OneAscent Financial Services LLC acquired a new stake in Health Catalyst, Inc. (NASDAQ:HCAT) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 13,754 shares of the company’s stock, valued at approximately $97,000.

A number of other institutional investors also recently added to or reduced their stakes in HCAT. Quantbot Technologies LP purchased a new stake in shares of Health Catalyst in the fourth quarter valued at approximately $29,000. Stoneridge Investment Partners LLC acquired a new stake in Health Catalyst in the fourth quarter valued at $77,000. Quadrature Capital Ltd purchased a new stake in shares of Health Catalyst during the 3rd quarter worth $84,000. Virtu Financial LLC acquired a new position in shares of Health Catalyst during the 4th quarter worth $110,000. Finally, Intech Investment Management LLC purchased a new position in shares of Health Catalyst in the 3rd quarter valued at about $145,000. Hedge funds and other institutional investors own 85.00% of the company’s stock.

Insiders Place Their Bets

In other news, General Counsel Benjamin Landry sold 13,827 shares of the company’s stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $4.55, for a total transaction of $62,912.85. Following the completion of the sale, the general counsel now directly owns 160,437 shares in the company, valued at $729,988.35. This represents a 7.93 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, insider Linda Llewelyn sold 6,442 shares of the stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $5.80, for a total value of $37,363.60. Following the completion of the transaction, the insider now directly owns 92,260 shares in the company, valued at $535,108. This trade represents a 6.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 56,530 shares of company stock valued at $299,572 over the last quarter. Company insiders own 2.50% of the company’s stock.

Health Catalyst Stock Down 3.1 %

HCAT opened at $4.01 on Friday. The business has a 50-day moving average of $4.89 and a two-hundred day moving average of $6.73. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.41 and a quick ratio of 1.41. Health Catalyst, Inc. has a 12 month low of $3.72 and a 12 month high of $9.24. The stock has a market capitalization of $281.55 million, a price-to-earnings ratio of -2.97 and a beta of 1.43.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the stock. Citigroup decreased their price objective on shares of Health Catalyst from $10.50 to $10.00 and set a “buy” rating on the stock in a report on Friday, January 10th. Stephens lowered their price target on Health Catalyst from $7.00 to $5.00 and set an “equal weight” rating on the stock in a report on Thursday, March 6th. Wells Fargo & Company lowered their target price on Health Catalyst from $13.00 to $10.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Stifel Nicolaus cut their price target on Health Catalyst from $10.00 to $5.00 and set a “hold” rating for the company in a research note on Thursday, February 27th. Finally, KeyCorp upgraded Health Catalyst from a “sector weight” rating to an “overweight” rating and set a $9.00 price objective for the company in a research report on Wednesday, January 8th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Health Catalyst presently has a consensus rating of “Moderate Buy” and a consensus price target of $9.27.

Health Catalyst Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.